Advanced Search

Technical Analysis for AYLA - Ayala Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 13.41 3.07% 0.40
AYLA closed up 3.07 percent on Friday, March 5, 2021, on 20 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical AYLA trend table...
Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish 3.07%
1,2,3 Pullback Bullish Bullish Swing Setup 3.07%
Wide Bands Range Expansion 3.07%
Gapped Down Weakness 3.07%
Oversold Stochastic Weakness 3.07%
Older End-of-Day Signals for AYLA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% 2 days ago
Up 3% 2 days ago
Up 2% 2 days ago
Up 1% 2 days ago
60 Minute Opening Range Breakdown 3 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology. It is focused on the development and commercialization of small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Wilmington, DE.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Drugs Oncology Drug Development Wilmington Medical Tests Biomarker Precision Medicine Targeted Therapy Biomarkers Companion Diagnostic Molecule Therapeutics Aggressive Cancers

Is AYLA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 22 Ayala Pharmaceuticals To Raise $25M Via Private Stock Placement; Shares Pop 16%
Feb 19 Ayala Pharmaceuticals Raises $25M Via Equity To Fund AL102 Development In Connective Tissue Tumors
Feb 19 Ayala Pharmaceuticals receives $25M strategic financing
Feb 19 Ayala Pharmaceuticals Announces $25 Million Strategic Financing
Feb 19 Companies Like Ayala Pharmaceuticals (NASDAQ:AYLA) Are In A Position To Invest In Growth
Feb 12 The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
Jan 28 Dosing underway in Ayala Pharma's AL101 mid-stage study in breast cancer
Jan 28 Ayala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101 for the Treatment of Patients with Notch-Activated Triple Negative Breast Cancer
Jan 20 Ayala Pharmaceuticals (AYLA) Soars: Stock Adds 13.2% in Session
Jan 13 Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small & Microcap Virtual Investor Conference
See more AYLA news...

Indicators

Indicator Value
52 Week High 28.68
52 Week Low 8.62
Average Volume 40,425
200-Day Moving Average 12.63
50-Day Moving Average 14.51
20-Day Moving Average 17.08
10-Day Moving Average 16.51
Average True Range 1.74
ADX 46.12
+DI 33.83
-DI 23.86
Chandelier Exit (Long, 3 ATRs ) 23.45
Chandelier Exit (Short, 3 ATRs ) 18.17
Upper Bollinger Band 22.66
Lower Bollinger Band 11.50
Percent B (%b) 0.17
BandWidth 65.32
MACD Line 0.10
MACD Signal Line 0.86
MACD Histogram -0.765
Fundamentals Value
Market Cap 171.35 Million
Num Shares 12.8 Million
EPS -99999.99
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 43.25
Price-to-Book 2.86
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.71
Resistance 3 (R3) 14.73 14.32 14.49
Resistance 2 (R2) 14.32 13.99 14.31 14.42
Resistance 1 (R1) 13.86 13.78 14.09 13.84 14.35
Pivot Point 13.45 13.45 13.57 13.44 13.45
Support 1 (S1) 13.00 13.12 13.23 12.98 12.47
Support 2 (S2) 12.59 12.92 12.58 12.40
Support 3 (S3) 12.13 12.59 12.33
Support 4 (S4) 12.11